When you absolutely have to recruit patients on time.
Accell joins a Global CRO Strategic Alliance
Maximax Pharmaceutical Research Inc. launches a global CRO Development Group and expands its strategic alliances with several regional CRO’s to increase the scale, scope and geographic locations of its services to Bio-pharmaceutical companies and research institutions.
The four CRO’s joining the MPR CRO Alliance are: ACCELL Clinical Research (Russia and Ukraine), Cromos Pharma (USA based CEE CRO), Fortis Clinical Research (India), and Research Development RA. S.A. (South America).
A full version of the press release is available: